Psyence Biomedical (PBM) Total Liabilities (2023 - 2026)
Psyence Biomedical's (PBM) quarterly Total Liabilities came in at $623190.0 in Q1 2026, up 4.85% year-on-year from $594366.0 in Q1 2025, and down 33.92% quarter-over-quarter from $943068.0 in Q3 2025.
Psyence Biomedical (PBM) Total Liabilities (2023 - 2026) Analysis & Trends
Psyence Biomedical's Total Liabilities history runs 4 years deep, the most recent figure standing at $623190.0 for Q1 2026.
- On a quarterly basis, Total Liabilities rose 4.85% year-over-year to $623190.0 in Q1 2026; TTM through Mar 2026 was $623190.0, a 4.85% increase from a year earlier, with the FY2026 full-year figure at $623190.0, up 4.85% from the prior year.
- Total Liabilities retreated to $623190.0 in Q1 2026 per PBM's latest filing, from $943068.0 in the prior quarter.
- Across five years, Total Liabilities topped out at $12.1 million in Q1 2024 and bottomed at $28.75 in Q3 2023.
- The 4-year median for Total Liabilities is $943068.0 (2025), against an average of $2.8 million.
- Across the five-year window, Total Liabilities surged 12203981.11% in 2024 and slumped 95.09% in 2025, its largest moves.
- Year by year, Total Liabilities stood at $28.75 in 2023, then jumped by 12203981.11% to $3.5 million in 2024, then sank by 73.12% to $943068.0 in 2025, then slumped by 33.92% to $623190.0 in 2026.
- Per Business Quant, the three latest PBM Total Liabilities figures stand at $623190.0 (Q1 2026), $943068.0 (Q3 2025), and $594366.0 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 60.46 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 177.22 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 3.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 7.33 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 7.12 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.45 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.48 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.62 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 753.82 Mn |
| 10 | Psyence Biomedical | 1.56 Mn | 1.56 Mn | - | 623,190.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 623,190.00 |
| Sep 30, 2025 | 943,068.00 |
| Mar 31, 2025 | 594,366.00 |
| Sep 30, 2024 | 3.51 Mn |
| Mar 31, 2024 | 12.10 Mn |
| Sep 30, 2023 | 28.75 |
| Mar 31, 2023 | 1.79 Mn |